Brief: Sprint Bioscience Q3 Operating Loss Narrows To SEK 8.2 Mln
Oct 23 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q3 NET SALES SEK 4.4 MILLION VERSUS SEK 0 MILLION YEAR AGO
* Q3 OPERATING LOSS SEK 8.2 MILLION VERSUS LOSS SEK 8.9
MILLION
YEAR AGO
Source text for Eikon: ID:nWkrb5DXMS
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program